Description
Torseheal (Torsemide) 40 mg
Torseheal 40 mg is identified as a torsemide tablet. Torsemide is a loop diuretic used to reduce excess fluid and swelling in conditions such as heart failure and certain kidney or liver disorders. It is also used in some settings for blood pressure control.
Active Ingredient and Medicine Class
The verified active ingredient is torsemide. It belongs to the loop diuretic class and is described in prescribing information as a diuretic of the pyridine-sulfonylurea class.
Established Medical Uses
Official prescribing information for torsemide tablets states that it is indicated for edema associated with heart failure, renal disease, or hepatic disease. U.S. labeling for some torsemide products also includes treatment of hypertension.
How It Works
Torsemide acts in the thick ascending limb of the loop of Henle in the kidney, where it inhibits the Na+/K+/2Cl− transport system. This reduces reabsorption of sodium and chloride and increases the excretion of water, sodium, and chloride in the urine, which helps lower fluid overload.
Important Safety Information
Prescribing information highlights risks of hypotension, worsening renal function, electrolyte and metabolic abnormalities, and ototoxicity. Torsemide is contraindicated in patients with anuria and in those with known hypersensitivity to torsemide or sulfonylurea-derived drugs. Clinically significant interactions may occur with other diuretics, blood pressure medicines, NSAIDs, cholestyramine, and CYP2C9 substrates such as warfarin or phenytoin.
Possible Side Effects
Commonly reported adverse effects include dizziness, increased urination, dehydration, low blood pressure, low sodium, low potassium, and increased creatinine. More serious reactions can include severe electrolyte disturbance, kidney problems, and hearing-related effects.
Scientific Evidence
Peer-reviewed reviews and meta-analyses indicate that torsemide is an effective loop diuretic for heart failure-related congestion. Comparative studies versus furosemide have shown consistent diuretic activity, while overall differences in major clinical outcomes such as mortality remain uncertain and have varied across analyses.
Medical Information Notice
This summary is for educational purposes only and is based on sources available at the time of review. It does not replace the official patient leaflet or assessment by a qualified healthcare professional.
Medical Sources
- DailyMed – TORSEMIDE tablets, prescribing information
- FDA – SOAANZ (torsemide) tablets, for oral use
- Shen et al. – “Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials,” Journal of Evaluation in Clinical Practice, 2019. PubMed
